Taisho Pharmaceutical wants to sell its French OTC business

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Wednesday, Japanese Taisho Pharmaceutical Holdings made an offer to Bristol-Myers Squibb to sell its French OTC medicine business UPSA for $1.6B.

Actual Topics